Sanara MedTech Inc. Common Stock (SMTI) Stock Price

SMTIStock

$34.57+2.49%52W

Market Cap$317.63M

P/E—

PEG Ratio—

Div yield—

Beta1.19

SMTI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)61.61%

Price vs S&P 500 (4W)0.13%

VGM Score54.51

P/CF (Annual)46.25x

Book Value / Share (Quarterly)$0.77

P/TBV (Annual)36.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)31.03%

Cash Flow / Share (Quarterly)$0.37

Price vs S&P 500 (YTD)35.23%

Gross Margin (TTM)93.06%

Net Profit Margin (TTM)-38.64%

EPS (TTM)$-3.88

10-Day Avg Trading Volume0.31M

EPS Excl Extra (TTM)$-3.88

Revenue Growth (5Y)45.91%

EPS (Annual)$-4.36

ROI (Annual)-72.36%

Gross Margin (Annual)92.71%

Net Profit Margin (5Y Avg)-20.87%

Cash / Share (Quarterly)$1.48

Revenue Growth QoQ (YoY)18.62%

ROA (Last FY)-51.50%

Revenue Growth TTM (YoY)-10.80%

EBITD / Share (TTM)$1.11

ROE (5Y Avg)-142.30%

Operating Margin (TTM)8.13%

Cash Flow / Share (Annual)$0.24

P/B Ratio44.66x

P/B Ratio (Quarterly)22.41x

Net Income / Employee (Annual)$-347,800

EV / Revenue (TTM)4.24x

Net Interest Coverage (TTM)0.95x

ROA (TTM)-43.04%

EV / EBITDA (TTM)36.14x

EPS Incl Extra (Annual)$-4.36

Current Ratio (Annual)1.80x

Quick Ratio (Quarterly)1.99x

3-Month Avg Trading Volume0.16M

52-Week Price Return2.49%

EV / Free Cash Flow (Annual)162.10x

Revenue / Employee (TTM)$756,300

Tangible BV / Share (Quarterly)$1.30

P/S Ratio (Annual)3.04x

Asset Turnover (Annual)1.41x

52-Week High$35.95

Operating Margin (5Y Avg)-11.50%

EPS Excl Extra (Annual)$-4.36

CapEx CAGR (5Y)23.17%

26-Week Price Return73.54%

Quick Ratio (Annual)1.54x

13-Week Price Return45.31%

Total Debt / Equity (Annual)7.74x

Current Ratio (Quarterly)2.28x

Enterprise Value$346.50M

Revenue / Share Growth (5Y)34.46%

Asset Turnover (TTM)1.15x

Book Value / Share Growth (5Y)-7.43%

Revenue / Employee (Annual)$954,800

Inventory Turnover (Annual)2.24x

Pretax Margin (Annual)-0.38%

Cash / Share (Annual)$1.85

3-Month Return Std Dev54.37%

Gross Margin (5Y Avg)89.56%

Net Income / Employee (TTM)$-310,900

ROE (Last FY)-632.53%

Net Interest Coverage (Annual)0.78x

EPS Basic Excl Extra (Annual)$-4.36

P/FCF (TTM)53.57x

Receivables Turnover (TTM)6.40x

EV / Free Cash Flow (TTM)103.44x

Total Debt / Equity (Quarterly)6.58x

EPS Incl Extra (TTM)$-3.88

Receivables Turnover (Annual)8.44x

ROI (TTM)-56.90%

P/S Ratio (TTM)3.84x

Pretax Margin (5Y Avg)-14.59%

Revenue / Share (Annual)$11.96

Tangible BV / Share (Annual)$1.24

Forward P/E74.73x

Price vs S&P 500 (52W)-16.07%

Year-to-Date Return48.05%

5-Day Price Return0.55%

EPS Normalized (Annual)$-4.36

ROA (5Y Avg)-20.61%

Net Profit Margin (Annual)-36.43%

Month-to-Date Return2.10%

Cash Flow / Share (TTM)$-0.60

EBITD / Share (Annual)$1.16

Operating Margin (Annual)7.08%

LT Debt / Equity (Annual)7.74x

P/CF (TTM)49.66x

ROI (5Y Avg)-27.77%

LT Debt / Equity (Quarterly)6.58x

EPS Basic Excl Extra (TTM)$-3.88

P/TBV (Quarterly)30.53x

P/B Ratio (Annual)35.14x

Inventory Turnover (TTM)2.42x

Pretax Margin (TTM)0.15%

Book Value / Share (Annual)$0.66

Price vs S&P 500 (13W)43.36%

Beta1.19x

P/FCF (Annual)146.83x

Revenue / Share (TTM)$9.38

ROE (TTM)-246.36%

52-Week Low$16.05

vGradeD

gGradeC

mGradeB

vgmGradeC

SMTI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.07	$0.09	+223.14%(+$0.16)
Q1 2026	May 11, 2026	-$0.22	$0.04	+118.18%(+$0.26)
Q4 2025	Mar 24, 2026	$0.11	-$0.19	-272.73%(-$0.30)
Q3 2025	Nov 12, 2025	-$0.21	-$3.52	-1537.21%(-$3.31)
Q2 2025	Aug 13, 2025	-$0.44	-$0.23	+47.73%(+$0.21)

SMTI Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.11

3.89

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.57
ISRGIntuitive Surgical Inc.	D	B	C	$372.60
EWEdwards Lifesciences Corp	D	C	B	$90.21
STESTERIS plc	C	B	C	$233.78
ZBHZimmer Biomet Holdings, Inc.	B	C	B	$100.91
SNNSmith & Nephew plc	B	C	C	$28.97
ALGNAlign Technology Inc	B	D	C	$157.58
MSAMine Safety Incorporated	C	C	B	$190.34
ESTAEstablishment Labs Holdings Inc.	F	A	C	$70.64
ENOVEnovis Corporation	B	D	C	$24.90
CDRECadre Holdings, Inc.	C	C	C	$30.74
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.74
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.07
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	D	$2.34
INGNInogen Inc	B	D	C	$5.50
LAKELakeland Industries Inc	B	D	B	$11.86
SPAISafe Pro Group Inc. Common Stock	F	C	D	$4.63
MYOMyomo Inc.	C	B	A	$1.60
APTAlpha Pro Tech, Ltd.	A	D	C	$5.35
NTRBNutriband Inc. Common Stock	F	D	C	$4.46
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	D	$0.69
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.50
LFWDLifeward Ltd. Ordinary Shares	B	D	B	$7.46
RGNTRegentis Biomaterials Ltd.	—	—	D	$2.00
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.03
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$3.01
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	D	$0.36
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.34
BBLGBone Biologics Corp Common Stock	—	—	D	$0.61
BBLGWBone Biologics Corp Warrants	—	—	F	$5.70
COCHWEnvoy Medical, Inc Warrant	—	—	C	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	D	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.45

About Sanara MedTech Inc. Common Stock

Sanara MedTech develops medical technologies for wound and skincare management across acute and post-acute care settings. Its portfolio includes CellerateRX for surgical wounds and BIAKOS for chronic wound care, addressing a substantial market opportunity. The company's comprehensive product offerings target improved clinical outcomes and reduced healthcare costs.